Why the study?
Does transcatheter aortic valve implantation provide robust evidence of safety and efficacy compared to surgical aortic valve replacement across different risk profiles?
Does transcatheter aortic valve implantation provide robust evidence of safety and efficacy compared to surgical aortic valve replacement across different risk profiles?
Answers are grounded in this paper and cite their sources.
This review cautions against the uncritical and rapid adoption of TAVI across lower-risk populations, highlighting significant gaps in evidence, trial biases, and unresolved safety concerns like paravalvular leaks and pacemaker requirements.
Transcatheter aortic valve implantation (TAVI) has emerged as one of the most popularly deployed interventional innovations of recent times. After addressing the inoperable and high-risk patients, it is application is being extended to intermediate and low-risk category. There is some disquiet about the strength of evidence on which the clinical application is based. Durability and pacemaker requirement are also areas of concern. This review highlights the areas of concern on these aspects. There is also a need to address these deficiencies in future trials and also bring updated database reports in the public domain.
No takes yet. Share an insight, caveat, or question.
Kunal Sarkar (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: